Tribunal chosen to resolve pharma claims against U.S.A., and to rule whether MFN clause imports other obligations into NAFTA

You are not logged in. If you are a subscriber, please Login to access. If you are not a subscriber, you can contact us for a rate quote at Alternatively, you can sign up to receive free email headlines here.